Trial Profile
Review of Management Strategies in Dementia
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 19 Feb 2024
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease; Dementia
- Focus Therapeutic Use
- Acronyms REMIND
- Sponsors Ortho-McNeil Neurologics
- 19 Nov 2012 New trial record
- 19 Nov 2012 New trial record